Fed governors may dissent against Powell amid Trump pressure - WSJ’s Timiraos
LONDON - Belluscura PLC (AIM: BELL), a UK-based medical device company, has announced that it will hold a General Meeting at the offices of Dowgate Capital Limited in London at 11:00 a.m. on February 28, 2025. The purpose of the meeting is to discuss the details of a recently proposed fundraising initiative and to vote on resolutions necessary for its completion.
The fundraising, previously mentioned in announcements on February 6, 7, and 11, 2025, involves the issuance of new ordinary shares. These shares are intended to be admitted to trading on the AIM market of the London Stock Exchange (LON:LSEG). The company has confirmed that the WRAP Retail Offer Shares are expected to be issued on or around March 4, 2025, subject to shareholder approval of the resolutions. This will be followed by the issuance of 56,534,389 VCT/EIS Placing Shares. Additionally, 109,616,986 Conditional Placing Shares are anticipated to be issued on or around March 5, 2025, also contingent upon the passing of the resolutions.
Shareholders received a circular on February 11, 2025, which included a Notice of General Meeting and detailed information about the fundraising initiative. Belluscura has also made the circular available on its website for public viewing.
The company has outlined a timetable for the principal events associated with the fundraising. This includes the crediting of shares in uncertificated form to CREST accounts and the posting of share certificates for the new ordinary shares by the registrar, expected to occur within 14 days of each respective admission.
This announcement is based on a press release statement and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of English law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). Upon the publication of this announcement via a Regulatory Information Service, such inside information is now considered to be in the public domain.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.